 |
1 Disease |  |
3 Trials |
|
3 Trials |  |
623 News |  |
| «123456» |
- ||||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
Enrollment change: AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) - Jun 8, 2021
P2/3, N=144, Recruiting, Sponsor: NeuroRx, Inc.
N=288 --> 144
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
https://t.co/1lbwNqqU9D $rlf $rlfrf $nrxp #Aviptadil @US_FDA @BAG_OFSP_UFSP @EMA_News @tagesanzeiger @Swissquote @FuW_News @cashch (Twitter) - Jun 6, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Is there any information currently avaible for the inhaled aviptadil ? Like data and statistic‘s ? (Twitter) - Jun 2, 2021
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: https://t.co/EyGPrj5pbL @KantonsspitalSG recruited Patients for #Aviptadil #COVID19 $rlf $rlftf #Advita-lifesience @BAG_OFSP_UFSP @EMA_News @tagesanzeiger @20min @NZZ @mdenator @miki84codreanu @MC67_153 @SPACFishing @PedroAlfonsoDe3 (Twitter) - May 31, 2021
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Just endorse #rlf100 / #zyesami and the term "Covid long-hauler" can be scrapped from the dictionary.... (Twitter) - May 14, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
Enrollment open, Phase classification, Trial initiation date: Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS (clinicaltrials.gov) - May 13, 2021
P2, N=82, Recruiting, Sponsor: Prof. Dr. J
N=288 --> 144 Not yet recruiting --> Recruiting | Phase classification: P1 --> P2 | Initiation date: Jan 2021 --> May 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
so i hope @EMA_News more faster and #Aviptadil come soon👍 @20min @Blickch @SRF @WHO @ORFBreakingNews @tagesanzeiger @US_FDA (Twitter) - May 6, 2021
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
"will begin by testing Zyesami, a formulation of aviptadil acetate, produced by @NeuroRxPharma, Wilmington, Delaware, and the antiviral remdesivir (Veklury), developed by @GileadSciences" (Twitter) - Apr 22, 2021
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: NIH ACTIV-3 trial to test #Aviptadil is a synthetic version of Vasoactive Intestinal Peptide (VIP) in hospitalized patients with #COVID. This is a good trial as the 4 prior ACTIV-3 agents trialed have been monoclonal antibodies, which don't work in hospitalized late stage COVID (Twitter) - Apr 22, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
https://t.co/CMZaSwu9hk $rlf $rlftf #Aviptadil @BAG_OFSP_UFSP @US_FDA @EMA_News (Twitter) - Apr 20, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
New P2 trial: HOPE: A Clinical Study Evaluating Inhaled Aviptadil on COVID-19 (clinicaltrials.gov) - Apr 13, 2021
P2, N=80, Recruiting, Sponsor: Centurion Pharma
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
https://t.co/agGwzGMma0 #Aviptadil #AviptadilStopsCovid $rlf $rlftf @NeuroRxPharma @US_FDA @SteveFDA @EMA_News @PedroAlfonsoDe3 @mdenator @BAG_OFSP_UFSP @focusgesundheit @20min @sebastiankurz @Bundesrat_CH @bundesrat (Twitter) - Apr 12, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Why hasn’t #rlf-100 been approved for EAU? (Twitter) - Apr 8, 2021
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
https://t.co/ZNRQUVMOFu #Aviptadil #AviptadilStopsCovid $rlf $rlftf @NeuroRxPharma @cheddar @US_FDA @krone_at @derStandardat @tagesanzeiger @vaterlandnews @OeParl @Bundesrat_CH @focusgesundheit @Swissquote (Twitter) - Apr 5, 2021
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Great news @JohnNosta! More good news on the therapeutics front as well today. Aviptadil (Zyesami) reported the first stat sig trial data in critical Covid-19 patients with respiratory failure. Will be a key player going forward, variant agnostic. https://t.co/mHR2hKbWML (Twitter) - Mar 29, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
$rlf $rlftf #aviptadil (Twitter) - Mar 20, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
$RLFTF #RLF-100 Let’s go baby! (Twitter) - Mar 16, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil $rlf is the EAP ended? come now the EUA?🤔🤔 $rlftf $rlf #Avipztadil @US_FDA @FDA_Drug_Info @YoDoctorYo @SteveFDA @mdenator @miki84codreanu @bradlessard @Bill01234567890 @PedroAlfonsoDe3 (Twitter) - Mar 16, 2021
- Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx, Zyesami IV (aviptadil intravenous) / Relief Therap, NeuroRx
[VIRTUAL] Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide () - Mar 14, 2021 - Abstract #ATS2021ATS_892;
The improvement in patients on ECOM was similar to that seen in patients treated with conventional mechanical ventilation. Available data from blood gases showed stark increases in PaO2:FiO2 ratio after the 2nd dose (Median increase = 92.5, IQR = 74) and at 24 hours after the 3rd dose (Median increase over baseline 84.5, IQR = 110).
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#AviptadilStopsCovid $rlf $rlftf🚀🚀🚀 hope EUA come soon @US_FDA @FDA_Drug_Info @SteveFDA @BAG_OFSP_UFSP (Twitter) - Feb 27, 2021
- |||||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
Enrollment open: AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) - Feb 21, 2021
P2/3, N=288, Recruiting, Sponsor: NeuroRx, Inc.
Available data from blood gases showed stark increases in PaO2:FiO2 ratio after the 2nd dose (Median increase = 92.5, IQR = 74) and at 24 hours after the 3rd dose (Median increase over baseline 84.5, IQR = 110). Not yet recruiting --> Recruiting
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Aviptadil works way better. Will get EUA very soon. Time to invest in #RLFTF (Twitter) - Feb 14, 2021
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
i hope @US_FDA know #Aviptadil works👍👍 (Twitter) - Feb 10, 2021
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Have you heard anything about Aviptadil from NeuroRX? (Twitter) - Feb 8, 2021
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx, Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
A good alternative is to have therapeutic medications on hand that can combat all #Covid19 variants. There’s #Leronlimab and #Aviptadil. Both drugs completed P3 trials and are available by eIND and EAP. #LeronlimabStopsCovid #AviptadilStopsCovid #GetTheWordOut $CYDY $RLFTF (Twitter) - Feb 8, 2021
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
@DrWoodcockFDA @US_FDA @CDCDirector @CDCgov #SARSCoV2 #aviptadil #COVIDー19 #eua #WhyTheDelay (Twitter) - Feb 4, 2021
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: What do you think about the pending #aviptadil data readout from NeuroRX? Are you following this? How quickly can this be delivered to critical patients on ventilators? Could this finally help ICUs across the country? (Twitter) - Jan 27, 2021
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: What do you think about the pending #aviptadil data readout from NeuroRX? Are you following this? How quickly can this be delivered to critical patients on ventilators? Could this finally help ICUs across the country? (Twitter) - Jan 27, 2021
- || aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Maybe share something new. How about the importance of vitamin d? Zinc? How about aviptadil? We kept repeating the same few things. Washing hands is great but it’s physical transmission through touch has not been shown to be a common form of transmission. (Twitter) - Jan 27, 2021
- | aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
What about RLF-100? (Twitter) - Jan 14, 2021
- || aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx, Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
“This is our last hope” Why not discuss therapeutics of great promise & known MOA that await final trial data? It is not anti-science to question FDA. Safe and “may be” effective is what EUA is for. Why not publicly alert doctors to EAP & eIND availability? #leronlimab #RLF100 (Twitter) - Jan 5, 2021
- | aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
One exists....aviptadil (Twitter) - Dec 23, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx, lenzilumab (KB003) / Humanigen, Saccovid (CD24Fc) / Merck (MSD)
The medical community ought to put as much emphasis & resources on top #COVID19 host-mediated therapeutics like CD24Fc, Aviptadil, Lenzilumab, and others as they have put on viral targeting mechanisms that are prone to mutational risk like vaccines https://t.co/tPw5W1WRSj (Twitter) - Dec 20, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
As FDA reviews its covid EUA, full formula for advanced US biotech drug published on official Chinese news outlet. Disclosure signals China’s interest in work of NeuroRx Pharma (RLF-100) now considered critical for US efforts to combat pandemic in ICUs. https://t.co/z22d7DqleO (Twitter) - Dec 8, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
As FDA reviews covid EUA, full formula for advanced US biotech drug published on official Chinese news outlet. Disclosure signals China’s interest in work of NeuroRx Pharma (RLF-100) now considered critical for US efforts to combat pandemic in ICUs. https://t.co/z22d7DqleO (Twitter) - Dec 8, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
As FDA reviews covid EUA, full formula for advanced US biotech drug published on official Chinese news outlet. Disclosure signals China’s interest in work of NeuroRx Pharma (RLF-100) now considered critical for US efforts to combat pandemic in ICUs. https://t.co/z22d7DqleO (Twitter) - Dec 8, 2020
- |||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: 2) @DelaCruzYaleMed @edschenck @Terri_Hough @AnneMStey reports show a fast discharge: "a 54-yo man who developed COVID & rejection of a double lung transplant came off a ventilator within 4 days of tmnt w RLF-100. Similar results seen >15 pts treated under emergency use" (Twitter) - Dec 8, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical, FDA event, P2/3 data: 1) @edschenck @AnneMStey @Terri_Hough @DelaCruzYaleMed Just want to share that yesterday the phase 2/3 trial of rlf-100 recruited its last patient (165) so after 28 days the fda will have this group and 200+ from the expanded access program to evaluate a possible approval. Early (Twitter) - Dec 8, 2020
- | aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
#AviptadilStopsCovid #RLF100 (Twitter) - Dec 6, 2020
- || aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx, Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Read your article re FDA vaccine delay. Same with COVID TREATMENTS like #Leronlimab and #Aviptadil - In trials since April/May - MOA against COVID is known - Qualify for EUA: are SAFE and without doubt “may be” effective - FDA is taking so long while so many die - Can you help? (Twitter) - Dec 5, 2020
- |||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical, FDA event: ER Doctor’s surprise recovery puts spotlight on exclusive covid treatment. Del startup may be welcoming FDA curious delay granting wider approval for its RLF-100. Observers speculate this ex-Biogen biologic reserved for well rich, well connected patients. https://t.co/TdHJIJBDgt (Twitter) - Dec 4, 2020
- | aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
https://t.co/odgXTbfLtx 💪💪 #RLF100 #Aviptadil @SwissCovid @SRF @bradlessard @witts11 @Gezwitsche_r @PedroAlfonsoDe3 @miki84codreanu @YoDoctorYo @SteveFDA @US_FDA (Twitter) - Dec 4, 2020
- |||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical, FDA event: #Aviptadil will save thousands of people once the #FDA approves the pending #EUA. We have seen critical #ICU patients recover within a matter of days after receiving this drug. #COVID19 #aviptadilstopscovid #RFL100 @DrWoodcockFDA @SteveFDA @CDCDirector (Twitter) - Dec 1, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Prominent Delaware startup quietly delivers hope to Covid-strained ICUs with biotech therapy once found in Biogen’s pulmonary pipeline. Skeptics of covid therapy “gold rush” point to NeuroRx's RLF100 antiviral as rare success story (EAP now; EUA pending). https://t.co/F4HlAHIFNe (Twitter) - Nov 28, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: @mlipsitch PLEASE research clinical trials #aviptadil. SAFE peptide saving critical ICU patients. Compassionate use available!Just fill out paperwork @NeuroRxPharma SHARE what you find with your network. @SteveFDA no EUA yet because its not #BigPharma #AviptadilStopsCovid (Twitter) - Nov 28, 2020
- |||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: Yet no one in America is demanding why the same support is not given to a drug that has been sending the sickest patients home for months! No accountability just like @tedcruz is asking for. @AOC @CDCDirector @US_FDA @SteveFDA #Aviptadil #COVID19 #EUA (Twitter) - Nov 27, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: 1) @DelaCruzYaleMed @Terri_Hough @edschenck @amandasximd @PaulBerglMD @runwithscalpels Apologies if this is already being considered. Your hospitals are eligible to request rlf-100 in its placebo controlled expanded access clinical trial for critical/severe respiratory distress. (Twitter) - Nov 26, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Delaware startup quietly delivers hope to Covid-strained ICUs with biotech therapy once found in Biogen’s pulmonary pipeline. Skeptics of covid therapy “gold rush” point to NeuroRx's aviptadil as rare success story in Covid fight (EAP now; EUA pending). https://t.co/F4HlAHIFNe (Twitter) - Nov 26, 2020
- ||| aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Clinical: Yes, plasma and Remdesivir do not work. However, Aviptadil does, and no one knows about it. Please for the sake of humanity through health, psychologically, and economically look into Aviptadil (RLF-100). 72% recovery rate from ICU through Emergency Access Protocol. (Twitter) - Nov 25, 2020
- || aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
Absolutely crazy this hasn't been given EAU status yet, gets people of vents and back home. #aviptadilstopscovid #aviptadil https://t.co/tW6vEiSlQW (Twitter) - Nov 25, 2020